depotentiation < deprenyl < depress

Facettes :

List of bibliographic references indexed by deprenyl

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
003453 (2000)	Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]	R -(−)-Deprenyl Inhibits Monocytic THP-1 Cell Neurotoxicity Independently of Monoamine Oxidase Inhibition
003464 (2000)	E. Kwan [Canada] ; G. B. Baker [Canada] ; A. Shuaib [Canada] ; L. Ling [Canada] ; K. G. Todd [Canada]	N‐methyl,N‐propargyl‐2‐phenylethylamine (MPPE), an analog of deprenyl, increases neuronal cell survival in thiamin deficiency encephalopathy
003807 (1999)	K. Kitani [Japon] ; S. Kanai [Japon] ; G. O. Ivy [Canada] ; M. C. Carrillo [Argentine]	Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl : a possible antioxidant strategy
003814 (1999)	D. L. Gelowitz [États-Unis] ; I. A. Paterson [Canada]	Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration
003877 (1998)	Xin-Min Li [Canada] ; Augusto V. Juorio [Canada] ; Jin Qi [Canada] ; Alan A. Boulton [Canada]	L‐deprenyl potentiates NGF‐induced changes in superoxide dismutase mRNA in PC12 cells
003973 (1998)	Kathryn G. Todd [Canada] ; Roger F. Butterworth [Canada]	Increased neuronal cell survival after L‐deprenyl treatment in experimental thiamine deficiency
003A01 (1998)	Kenichi Kitani [Japon] ; Setsuko Kanai ; Gwen O. Ivy [Canada] ; Maria Cristina Carrillo [Argentine]	Assessing the Effects of Deprenyl on Longevity and Antioxidant Defenses in Different Animal Models
003B63 (1997)	Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada]	R(−)-Deprenyl Potentiates Dopamine-Induced Cytotoxicity toward Catecholaminergic Neuroblastoma SH-SY5Y Cells
003C35 (1997)	I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis]	Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
003C54 (1997)	C. Thiffault [Canada] ; L. Lamarre-Theroux [Canada] ; R. Quirion [Canada] ; J. Poirier [Canada]	L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse
003D02 (1996)	W G Tatton [Canada] ; J S Wadia ; W Y Ju ; R M Chalmers-Redman ; N A Tatton	(-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
003E39 (1996)	X. Zhang [Canada] ; D. Zuo [Canada] ; B. A. Davis [Canada] ; A. A. Boulton [Canada] ; P. H. Yu [Canada]	Immunohistochemical evidence of neuroprotection by R(−)‐deprenyl and N‐(2‐hexyl)‐N‐methylpropargylamine on DSP‐4‐induced degeneration of rat brain noradrenergic axons and terminals
003E90 (1996)	W. G. Tatton [Canada] ; R. M. E. Chalmers-Redman [Canada]	Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration
004068 (1995)	F. Zhang [Canada] ; P. M. Richardson [Canada] ; D. P. Holland [Canada] ; Q. Guo [Canada] ; Q. Tatton [Canada]	CNTF or (−)‐deprenyl in immature rats: Survival of axotomized facial motoneurons and weight loss
004095 (1995)	C. Thiffault [Canada] ; N. Aumont ; R. Quirion [Canada] ; J. Poirier	Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain
004202 (1994)	Maria Cristina Carrillo [Japon] ; Kenichi Kitani [Japon] ; Setsuko Kanai [Japon] ; Yuko Sato [Japon] ; Kyoko Miyasaka [Japon] ; Gwen O. Ivy [Canada]	The effect of a long term (6 months) treatment with (−)deprenyl on antioxidant enzyme activities in selective brain regions in old female fischer 344 rats
004244 (1994)	N. A. Seniuk [Canada] ; J. T. Henderson [Canada] ; W. G. Tatton [Canada] ; J. C. Roder [Canada]	Increased CNTF gene expression in process‐bearing astrocytes following injury is augmented by R(−)‐deprenyl
004286 (1994)	C. Oh [Canada] ; B. Murray [Canada] ; N. Bhattacharya [Canada] ; D. Holland [Canada] ; D. Tatton [Canada]	(–)‐Deprenyl alters the survival of adult murine facial motoneurons after axotomy: Increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants
004549 (1992)	James W. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]	The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
004590 (1992)	A. Jon Salo [Canada] ; W. G. Tatton [Canada]	Deprenyl reduces the death of motoneurons caused by axotomy
004628 (1992)	M. Schulzer [Canada] ; E. Mark ; D. B. Calne	The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "deprenyl" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "deprenyl" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    deprenyl
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022